<PAGE> 1
U.S. SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 12b-25
NOTIFICATION OF LATE FILING
Commission File Number 0-28666
-------------
(Check One):
Form 10-K and Form 10-KSB X Form 11-K Form 20-F Form 10-QSB
--- --- --- ---
Form N-SAR
---
For period ended April 30, 2000 .
------------------
Nothing in this Form shall be construed to imply that the Commission
has verified any information contained herein.
If the notification relates to a portion of the filing checked above,
identify the Item(s) to which the notification relates: N/A
---------------------
PART I
REGISTRANT INFORMATION
Full name of registrant American Bio Media Corporation
-------------------------------
Address of principal executive office (street and number) 122 Smith Road
--------------
City, state and zip code Kinderhook, NY 12106
--------------------
PART II
RULES 12b-25(b) AND (c)
If the subject report could not be filed without unreasonable effort or
expense and the registrant seeks relief pursuant to Rule 12b-25(b), the
following should be completed. (Check box if appropriate)
(a) The reasons described in reasonable detail in Part III of this
form could not be eliminated without unreasonable effort or
expense;
(b) The subject annual report on Form 10-KSB will be filed on or
before the 15th calendar day following the prescribed due date; X
--
and
<PAGE> 2
(c) The accountant's statement or other exhibit required by Rule
12b-25(c) has been attached if applicable.
PART III
NARRATIVE
State below in reasonable detail the reasons why the Form 10-KSB could
not be filed within the prescribed time period. (Attach extra sheets if needed.)
The Registrant's internal accounting staff has encountered delays in
finalizing the Registrant's financial statements on a timely basis due to
problems in gathering certain supporting information from third parties. As a
result, the Form 10-KSB for the period ended April 30, 2000 has not been
completed and accordingly this notification is being filed.
PART IV
OTHER INFORMATION
(1) Name and telephone number of person to contact in regard to this
notification:
John F. Murray, Chief Financial Officer (518) 758-8158
-----------------------------------------------------------------------
(Name) (Area Code) (Telephone Number)
(2) Have all other periodic reports required under Section 13 or 15(d) of
the Securities Exchange Act of 1934 or Section 30 of the Investment
Company Act of 1940 during the preceding 12 months or for such shorter
period that the registrant was required to file such report(s) been
filed? If the answer is no, please identity report(s).
Yes X No
---
(3) Is it anticipated that any significant change in results of operations
from the corresponding period for the last fiscal year will be
reflected by the earnings statements to be included in the subject
report or portion thereof?
Yes No X
---
2
<PAGE> 3
SIGNATURE
AMERICAN BIO MEDICA CORPORATION
-------------------------------
(Name of Registrant as Specified in Charter)
Has caused this notification to be signed on its behalf by the undersigned
thereunto duly authorized.
Date: July 28, 2000 By: /s/ Stan Cipkowski
-----------------------------------------
Stan Cipkowski, Chairman of the
Board of Directors, President
and Chief Executive Officer
